Purchase Order 75D30121P12612
Award Date
9/7/21
Potential Completion Date
9/30/21
Potential Value
$48K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $43,168.00, is for the delivery of a TEC-REAGENT KIT and has a completion date of September 15, 2022. Oxford Nanopore Technologies Inc. is a leading provider of nanopore-based sequencing equipment, consumables, and associated services to federal...
This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
This firm fixed-price purchase order, valued at $16,199.00, was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides for the delivery of Oxford Nanopore's VOLTRAX V2 CAPEX equipment, which is part of their nanopore-based electronic systems used for real-time analysis of genetic materials and other biological molecules. The contract has no set-aside designation. Oxford Nanopore...
This is a $41,180 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the acquisition of MinION MK1C basic starter packs on behalf of the CDC's operations in Thailand. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for DNA, RNA, and protein analysis, and has secured numerous prime federal contracts from...
This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the delivery of RNA sequencing kits, ligation sequencing kits, rapid barcoding kits, and flow cells. The $70,000.00 firm-fixed-price purchase order was awarded by the Southeast Area office of a civilian federal agency. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts to provide...
The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company, to provide a GridION Mk1 capex sequencing system and associated lab equipment and supplies. The $126,680 contract has a completion date of December 13, 2022 and does not utilize a set-aside designation. Based on previous federal contract awards, Oxford Nanopore Technologies Inc. provides...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
This is a $161,638 firm-fixed-price purchase order awarded by the Northeast Area division of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of ROSEN - Oxford Nanopore FLO-PRO002 Promethion Flow Cell Packs, which are consumable supplies for Oxford Nanopore's PromethION DNA/RNA sequencing platform. The contract has a completion date of September 14, 2022 and does not have a set-aside designation....
Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was awarded a $9,350 firm fixed-price purchase order (Contract ID 75D30123P15957) by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, for equipment software licenses and warranties. The contract has an ultimate completion date of April 30, 2023 and does not utilize a set-aside. This award is part of Oxford Nanopore's broader portfolio of federal contracts, which include...